Uropathogenic Escherichia coli (UPEC) is the major causative agent of 20 uncomplicated urinary tract infections (UTIs). A common virulence genotype of UPEC 21 strains responsible for UTIs is yet to be defined, due to the large variation of virulence 22 factors observed in UPEC strains. We hypothesized that studying UPEC functional 23 responses in patients might reveal universal UPEC features that enable pathogenesis. 24
Introduction 34
Urinary tract infections (UTIs) are among the most common bacterial infections 35 in humans, affecting 150 million people each year worldwide (1). A high incidence of 36 recurrence and frequent progression to chronic condition exacerbates the negative impact 37 of UTIs on patients' quality of life and healthcare costs (2). Despite the magnitude of the 38 problem, treatment remains limited by a strain's susceptibility to available antibiotics, 39 which are often ineffectual (3-5). 40
The major causative agent of uncomplicated UTIs is Uropathogenic Escherichia 41 coli (UPEC), which is responsible for upwards of 70% of all cases (1). The majority of 42 our insights into UPEC pathogenesis have been obtained through in vitro assays, cell 43 culture systems, and animal models (6-9). While these studies have identified virulence 44 and fitness factors that are important for UPEC infection, how these studies translate to 45 human infection is not clear. As a result, we do not yet have a complete understanding of 46 UPEC physiology in the human urinary tract. Moreover, the genetic heterogeneity of 47 UPEC isolates, which carry diverse and functionally redundant virulence systems 48 including iron acquisition, adherence, and toxins, further complicates our understanding 49 of uropathogenesis (10-14). The different constellations of virulence factors and diverse 50 genetic backgrounds raise the question of whether different UPEC strains vary in their 51 strategies for pathogenesis. 52
Since defining conserved UPEC characteristics have proven elusive to 53 comparative genomics strategies, we hypothesized that comparing functional responses in 54 the context of the host may uncover disease-defining features. To that end, we directly 55 examined UPEC gene expression directly from 14 patients with documented significant 56 bacteriuria and presenting with uncomplicated UTI and compared it to the gene 57 expression of identical strains cultured to mid-exponential stage in filter-sterilized pooled 58 human urine. Despite the genetic diversity of the pathogen and the human hosts, we 59 identified a remarkably conserved gene expression program that is specific to human 60 infection, can be recapitulated in the mouse model of infection and bears all the 61 hallmarks of extremely rapid growth rate. Based on extensive analysis, we propose a 62 model where UPEC shut down all non-essential metabolic processes and commit all 63 available resources to rapid growth during human UTI. Critically, our discovery of a 64 common transcriptional program of UPEC in patients significantly expands our 65 understanding of bacterial adaptation to the human host and provides a platform to design 66 universal therapeutic strategies. 67
Results 68
Study design. To better understand UPEC functional responses to the human host, we 69 isolated and sequenced RNA from the urine (stabilized immediately after collection) 70 from fourteen otherwise healthy women diagnosed with UPEC-associated urinary tract 71 infection. To identify infection-specific responses, we cultured the same fourteen UPEC 72 isolates in vitro in filter-sterilized human urine (mid-exponential phase, 2-hour time point 73
in Fig S1) , and isolated and sequenced RNA from these cultures (study design and 74 quality control is described in detail in Methods section). Phylogenetic analysis showed 75 high degree of genetic diversity, as we identified strains belonging to 3 distinct 76 phylogroups ( Fig. S2) . The majority of UPEC isolates (10 of 14) belonged to the B2 77 phylogroup, which is consistent with previously published studies (2, 13, 16-18). 78
Although the majority (10 of 14) of patients had previous history of UTIs, we found no 79 relationship between patients' previous UTI history and bacterial genotype ( Fig. S2) . 80
Moreover, the fourteen clinical isolates showed a wide array of antibiotic resistance 81 phenotypes ( Fig. S2) . 82 83 Virulence factor expression is not specific to infection. We first assessed the virulence 84 genotype of the fourteen UPEC strains by looking at the presence or absence of a 85 comprehensive list of known virulence factors, including adhesins, toxins, iron 86 acquisition proteins, and flagella (9-14)( Fig. 1A) . As previously reported (13), B1 strains 87 appear to carry fewer virulence factors overall when compared to B2 strains, suggesting 88 that UTIs can be established by UPEC strains with vastly diverse virulence genotypes. 89
We then compared the levels of gene expression of these virulence factors following 90 culture in filter-sterilized urine ( Fig. 1B) to that during infection (Fig. 1C) . Gene 91 expression during infection and in urine showed strain-to-strain variability, which is 92 consistent with previous reports (15). Virulence factors were expressed at similar levels 93 in in vitro urine cultures and during infection. For example, iron acquisition systems were 94 expressed regardless of experimental condition ( Fig. 1B, C) . Notably, virulence factor 95 carriage varies greatly between UPEC strains and we did not discern any infection-96 specific gene expression among the virulence factors we examined (Fig S3) . 97
98
The UPEC core genome exhibits a common gene expression program during clinical 99 infection. To perform a comprehensive comparison of gene expression between the 100 different clinical UPEC strains, we identified a set of 2653 genes present in all 14 UPEC 101 strains in this study as well as the reference E. coli MG1655 strain (hereafter referred to 102 as the core genome; see Methods, Fig S4, Fig S5) . We then assessed the uniformity of 103 core genome expression of 14 isolates cultured in vitro in filter-sterilized urine. As 104 expected for bacterial strains cultured under identical conditions, we saw high correlation 105 of gene expression between any two isolates cultured in vitro ( Fig. 2A, B (blue box), with 106 median Pearson correlation coefficient of 0.92). Remarkably, the correlation of gene 107 expression was just as high between any two patient samples (median of 0.91, Fig. 2A , B 108 (red box)), while the correlation between in vitro urine and patient samples was 109 considerably lower (median of 0.73 ( Fig. 2A, B (green box)). The gene expression 110 correlation between in vitro and patient samples remained low, even when we directly 111 compared identical strains (i.e. HM56 cultured in vitro in urine vs. HM56 isolated from 112 the patient, median of 0.74, Fig. 2A, B (yellow box) ). This analysis suggested that UPEC 113 adopt an infection-specific gene expression program that is distinct from UPEC 114 undergoing exponential growth in urine in vitro. We confirmed this observation using 115 principal component analysis (PCA), which revealed that patient samples form a tight 116 cluster, distinct from in vitro cultures (Fig. 2C) , demonstrating the common 117 transcriptional state of UPEC during human UTI. 118
We also performed PCA analysis on in vitro (Fig. S6A, B ) and patient samples 119 ( Fig. S6C, D) separately, to ascertain whether there is any discernable effect of bacterial 120 phylogroup ( Fig. S6A , C) or patients' previous history of UTI ( Fig. S6B, D) on gene 121 expression. Interestingly, B1 and B2 strains did cluster separately and a number of genes 122 were expressed differentially in B1 and B2 backgrounds (Dataset S1, S2), suggesting 123 that variation in gene regulatory elements between phylogroups has a small but 124 discernable role in gene expression both in vitro and during infection. However, we 125 found that patients' history of UTI had no effect on bacterial gene expression. 126
Taken together, our data indicate diverse UPEC strains adopt a specific and 127 conserved transcriptional program for their core genome during human infection. 128 rates during infection are significantly higher than during mid-exponential growth in 138 urine. 139
We also observed infection-specific downregulation of pathways involved in 140 amino acid biosynthesis and sugar metabolism, and a general switch from expression of 141 sugar transporters to that of amino acid transporters ( Fig. 3B ) (with the exception of 4 142 sugar transporters that were expressed at higher levels in patients: ptsG, fruA, fruB, and 143 gntU. Fig. S6 ). Downregulation of sugar catabolism genes and upregulation of amino 144 acid transporters suggest a metabolic switch to a more specific catabolic program as well 145 as a scavenger lifestyle as examined in detail below. 146 147 A shift in metabolic gene expression during UTI to optimize growth potential. 148
During our analysis, we observed that 99% (on average 2621/2653 genes) of core 149 genome was expressed during in vitro culture, in contrast to only 94% in patient samples 150 (2507/2653 genes). Patient samples also contained higher proportion of genes expressed 151 at low levels when compared to in vitro samples. (Fig. S5) . Moreover, we noted that the 152 majority of differentially expressed genes were downregulated in patients (343/492 153 differentially expressed genes). On the other hand, 30% of all upregulated genes (48/149) 154 were ribosomal proteins. Together, these data gave us the first indication that UPEC may 155 undergo a global gene expression reprogramming during urinary tract infection. 156
Bacterial growth laws postulate that bacteria dedicate a fixed amount of cellular 157 resources to the expression of ribosomes and metabolic machinery. As a consequence, 158
higher growth rates are achieved by allocating resources to ribosome expression at the 159 expense of metabolic machinery production (16-21). However, this resource reallocation 160 between ribosomal and metabolic gene expression has not yet been measured in vivo. 161
First, we wanted to determine what proportion of the total transcriptome is 162 dedicated to core genome expression. We first hypothesized that during infection 163 transcription could shift from the core genome to the accessory genome, which is 164 enriched for virulence factors. However, we found that approximately 50% of total reads 165 mapped to the core genome regardless of whether the bacteria were isolated from the 166 patients or cultured in vitro ( Fig. 4A) . Therefore, our data indicated that a fixed 167 proportion of cellular resources were being dedicated to expression of conserved 168 ribosomal and metabolic machinery, regardless of external environment. 169
We next looked at r-protein expression. Remarkably, we found that almost 25% 170 of core genome reads mapped to r-proteins during infection, while this number was only 171 7% during exponential growth in urine ( Fig. 4B) . These findings support the idea of 172 extremely fast UPEC growth during UTI. Furthermore, this increase in r-protein 173 expression correlated with a marked decrease in the proportion of core genome reads 174 dedicated to the expression of catabolic genes (20% in vitro, 11% in patients, Fig. 4C ) 175 and amino acid biosynthesis genes (5% in vitro, 1% in patients, Fig. 4D ). Thus, our data 176 highlight a dramatic and conserved resource reallocation from metabolic gene expression 177 to replication and translational gene expression during human UTI. We postulate that this 178 resource reallocation is required to facilitate the rapid growth rate of UPEC in the host, 179 which has been previously documented (22) . (Fig 5B) . In contrast, the bacterial transcriptome during mouse infection 198 exhibited r-protein expression that was similar to the human infection ( Fig 5B) . 199
Additionally, the proportion of the transcriptome dedicated to catabolic gene expression 200 was highest during urine cultures and lowest during mouse and human infections, 201
indicating a negative correlation between the expression of r-protein and sugar 202 catabolism genes. (Fig 5C) . Overall, we show that exponential growth in rich medium 203 alone cannot recapitulate the transcriptional signature observed during human infection. 204 an infection-specific response. 206 207 Environment-responsive regulators facilitate patient-specific gene expression 208 program. We next sought to identify potential regulators involved in resource 209 reallocation that facilitate the infection-specific UPEC gene expression program. To do 210 so, we performed gene set enrichment analysis (GSEA) on E. coli co-regulated genes 211 (regulons). This analysis allowed us to identify regulons enriched in differentially 212 expressed genes. We identified 22 transcriptional factors whose regulon's expression was 213 statistically different between infection and in vitro cultures (Table S3 ). 18/22 regulons 214 were expressed at higher level during in vitro culture, and eight representative regulons 215 are shown in Fig. 6 . Overall, we found that these regulons accounted for 50% of 216 differentially expressed genes that were determined to be significantly down-regulated. In 217 contrast, only 6% of upregulated genes belonged to the 4 regulons that were expressed at 218 higher levels during infection. These included genes involved in the SOS response, as 219 well as purine synthesis (Table S3) . 220
In support of our previous data, the expression of catabolic genes controlled by 221 the Crp regulator was lower in patients compared to urine cultures. In conjunction with 222 the previously described role for Crp in resource reallocation (21) are freed as a result are then allocated to the transcription of genes (for example, r-231 proteins), which are required to maintain rapid growth rate. 232
233
As UPEC causes one of the most prevalent bacterial infections in humans, the 235 virulence mechanisms of UPEC infection have been well-characterized. However, while 236
we know that these virulence strategies (e.g., iron acquisition, adhesion, immune evasion) 237 are essential for establishing infection, UPEC strains can differ dramatically in the 238 specific factors that are utilized. Additionally, our data indicate that the expression of 239 virulence factors can change from patient to patient, suggesting that the need for a 240 specific factor might vary during the course of the infection. 241
In this study, we set out to uncover universal bacterial features during human 242
UTIs, regardless of the stage of the infection or patient history. To do so, we performed 243 transcriptomic analysis on bacterial RNA isolated directly from the urine of 14 patients 244 and compared it to the gene expression of identical strains cultured to mid-exponential 245 phase in sterile urine. Our analysis focused on the core genome as opposed to the more 246 commonly studied accessory genome, which contains the majority of the classical 247 virulence factors. This allowed us to identify a remarkably conserved gene expression 248 signature shared by all 14 UPEC strains during UTI. 249
Although frequently overlooked, bacterial metabolism is an essential component 250 of bacterial pathogenesis. Since the core genome is enriched for metabolic genes, we 251 anticipated that our study, for the first time, would illuminate the UPEC metabolic state 252 during human infection. Our data revealed an infection-specific increase in ribosomal 253 protein expression in all 14 UPEC isolates, which was suggestive of bacteria undergoing 254 rapid growth. While we did observe increased r-protein expression in exponentially 255 growing UPEC cultured in LB, these transcripts were dramatically more abundant in the 256 in the host in comparison to exponential growth in LB and supports recent studies that 258 have documented very rapid UPEC growth rate in patients (22, 24) . 259
Importantly, our analysis reveals how this growth rate can be achieved. We found 260 that regardless of external environment, ~50% of total gene expression is allocated to the 261 core genome, consisting of metabolic and replication machinery, which mediate bacterial 262 growth potential. When the infection-specific transcriptome was compared to that of 263 UPEC cultured to mid-exponential phase in urine, we observed that elevated levels of 264 ribosomal transcripts correlated with decreased levels of metabolic gene expression. We 265
propose that this reallocation of resources within the core genome drives the rapid growth 266 rate of UPEC during infection. 267
This resource reallocation is equivalent to what has been described as the 268 bacterial 'growth law'. Based on in vitro studies, the growth law proposes that increases 269 in ribosomal gene expression occurs at the expense of a cell's metabolic gene expression 270 (17, 19). Our analysis of UPEC gene expression directly from patients is consistent with 271 this hypothesis. In addition, regulatory network analysis revealed that multiple metabolic 272 regulons exhibit decreased transcript levels in patients suggesting an actively regulated 273 process. In contrast, synthesis of ribosomal RNA (rRNA) coordinates the expression of 274 ribosomal proteins by a translational feedback regulation mechanism (25, 26). rRNA 275 synthesis is proposed to be regulated by the competition of RNA polymerase between 276 transcription of rRNA operons and that of other genes, with some studies suggesting that 277 mid-log growing cells might require almost all RNA polymerase dedicated to rRNA 278 synthesis (30-33). Thus, decreased metabolic gene expression could allow the cell to 279 shift its allocation of RNA polymerase towards rRNA synthesis and as a result, ribosomal 280 protein expression. Although we cannot exclude other mechanisms, we propose that the 281 reallocation of RNA polymerase molecules from metabolic genes to rRNA and ribosomal 282 protein genes is a common feature adopted by diverse UPEC to promote rapid growth 283 during UTI. 284
Three recent studies have attempted to characterize UPEC gene expression in 285 patients with UTIs (15, 27, 28). These studies focused on the importance of virulence 286 factor expression in specific strains and have demonstrated changes in gene expression 287 between infection and in vitro cultures. It should be noted that all of these studies, as well 288 as our own, were performed using bacterial RNA isolated from patient urine (that was 289 immediately stabilized upon collection). As a result, we cannot exclude the possibility 290 that gene expression of UPEC residing in the bladder may differ from UPEC isolated 291 from patient urine. However, the fact remains that 14 patients with different histories of 292 UTIs all harbored a population of actively dividing bacteria in a remarkably specific 293 metabolic state, which we have also recapitulated in a mouse model of infection. 294
These findings raise a number of interesting questions. Firstly, how is rapid 295 growth rate beneficial to UPEC and how does it influence the tempo and mode of 296 bacterial evolution, especially with regards to genomic integrity and the acquisition of 297 antibiotic resistance? Secondly, what are the external cues that launch the infection-298 specific transcriptional response? While our study was not designed to identify infection-299 specific metabolites, our regulatory network analysis suggests that multiple 300 environmental cues might reinforce the suppression of metabolic gene expression. We 301 to limit UPEC growth during UTI and gain the upper hand on this pathogen. 303 304 Study design. Sample collection was previously described (15). Briefly, a total of 86 306 female participants, presenting with symptoms of lower UTI at the University of 307
Michigan Health Service Clinic in Ann Arbor, MI in 2012, were enrolled in this study. 308
The participants were compensated with a $10 gift card to a popular retail store. Clean 309 catch midstream urine samples from participants were immediately stabilized with two 310 volumes of RNAprotect (Qiagen) to preserve the in vivo transcriptional profile. De-311 identified patient samples were assigned unique sample numbers and used in this study. 312
Of the 86 participants, 38 were diagnosed with UPEC-associated UTIs (15). Of these, 19 313 samples gave us sufficient RNA yield of satisfactory quality. Five were used for a pilot 314 project (15), the remaining 14 were used in this study. and cultured statically at 37C for 2 hours. Six milliliters of this culture were stabilized 332 with RNAprotect (Qiagen) and used for RNA purification. 333 334 Antibiotic resistance profiling. As described in (15), identity and antibiotic resistance 335 profiles of UPEC isolates were determined using a VITEK2 system (BioMerieux). 336 337 RNA isolation and sequencing. RNA isolation protocol was previously described (15). 338
Briefly, samples were treated with proteinase K and total RNA was isolated using Qiagen 339
RNAeasy minikit. Turbo DNase kit (Ambion) was used to remove contaminating DNA. 340
Bacterial content of patient samples was enriched using MICROBenrich kit (Ambion). parameters. Alignment details can be found in Table S1 . Read counts were calculated 362 using HTseq htseq-count (union mode) (35). 363 364 Quality control. Since some of our clinical samples yielded lower numbers of bacterial 365 reads than desired (Table S1), we performed a comprehensive quality assurance to 366 determine if the sequencing depth of our clinical samples was sufficient for our analysis 367 (see Saturation curves and Gene expression ranges analysis below, Fig. S4, Fig. S5) . 368
Overall, all patient samples except for HM66 passed quality control (see gene expression 369 ranges analysis, Fig. S5 ). While we elected to keep all of the strains in our subsequent 370 analysis, this observation explains why the patient HM66 sample appears as an outlier in 371 sequencing file was subsampled to various degrees and number of genes detected in those 376 subsamples (y-axis) was graphed against number of reads in the subsample (x-axis). As 377 expected, all of the in vitro samples reached saturation (Fig S4, blue lines) . 378
Unfortunately, 6 out of our 14 samples did not reach saturation, which warranted us to 379 investigate further (see Gene expression ranges analysis) Fig S4, red lines) . 380
Core genome identification. Core genome for 14 clinical isolates and MG1655 was 381 determined using get_homologues (36). We explored multiple parameter values for our 382 analysis and their effect on final core genome, in the end we set the cut off of 90% of 383 sequence identity and 50% sequence coverage (similar results were obtained when using 384 different cutoffs). The intersection of three algorithms employed by get_homologues 385 contained 2653 gene clusters. 386 387 Gene expression ranges analysis. Due to low sequencing depth of 6 of our isolates, we 388 were worried we would not be able to detect genes expressed at low levels in those 389 samples. To evaluate whether we were losing information about low-level expression, we 390 compared a number of genes in the core genome that were expressed at different levels 391 (1000 TPMS, 100 TPMS, 10 TPMS and 1 TPM) between clinical samples that reached 392 saturation ( Fig. S5A) and those that did not (Fig. S5B) . Only one of the clinical samples 393 (HM66) seemed to lack genes expressed in the range of 1-10 TPMs. Thus, we conclude 394 that all but one sample (HM66) had sufficient coverage for downstream analysis. RNAprotect (Qiagen). All collected urine was pooled together and pelleted, and 413 immediately placed in the -80°C freezer. This collection was repeated every 45 minutes 414 five more times, resulting in six collected pellets consisting of bacteria and eukaryotic 415
cells. 416
For in vitro controls, UPEC strain HM43 was cultured overnight in LB. The next 417 morning, the culture was spun down, and the pellet washed twice with PBS. LB or 418 pooled human urine was then inoculated with the washed bacteria at a ratio of 1:100 and 419 incubated with shaking at 37°C for 3 hours. Cultures were then treated with bacterial 420 RNAprotect (Qiagen), pellets collected and stored at -80°C. 421
All the pellets were treated with both lysozyme and proteinase K, and then total 422
RNA was extracted using RNAeasy kit (Qiagen). Genomic DNA was removed using the 423 Turbo DNA free kit (ThermoFisher). Eukaryotic mRNA was depleted using dynabeads 424 covalently linked with oligo dT (ThermoFisher). The supernatant was collected from this 425 treatment, and the RNA was concentrated and re-purified using RNA Clean & 426
Concentrator kit (Zymo). Library preparation and sequencing was done as described The DESeq2 R package was used to compare in vitro urine cultures gene expression to that in patients. Each UPEC strain was considered an independent replicate (n = 14). Genes were considered up-regulated (down-regulated) if log 2 fold change in expression was higher (lower) than 2 (vertical lines), and P value < 0.05 (horizontal line). Using these cutoffs, we identified 149 upregulated genes, and 343 downregulated genes. GO/pathway analysis showed that large proportion of these genes belonged to one of the 4 functional categories (see legend) (B) Mean normalized expression for genes belonging to differentially expressed functional categories/pathways. Number of up(down)regulated genes belonging to each category is indicated next to the category name. 
